Cancer Risk Prediction Paradigm Shift: Using Artificial Intelligence to Improve Performance and Health Equity

By sjmartinez • July 25, 2022

Lee CI, Elmore JG. Cancer Risk Prediction Paradigm Shift: Using Artificial Intelligence to Improve Performance and Health Equity. J Natl Cancer Inst. 2022 Jul 25:djac143. doi: 10.1093/jnci/djac143. Epub ahead of print. PMID: 35876797.

Tags: General Internal Medicine, Hematology/Oncology, Publications

Oliceridine: Examining the clinical evidence, pharmacology, and contested mechanism of action of the first FDA-approved biased opioid agonist

Prommer EE. Oliceridine: Examining the clinical evidence, pharmacology, and contested mechanism of action of the first FDA-approved biased opioid agonist. J Opioid Manag. 2025 Sep-Oct;21(5):377-387.[...]

Analyses of adverse events and patient-reported outcomes with the toxicity index in cancer clinical trials

Gresham G, Henry NL, Bandos H, Calsavara VF, Cecchini RS, Diniz MA, Hays RD, Luu M, Kim S, Rogatko A, Yothers G, Ganz PA, Tighiouart[...]

Cardiovascular Multimorbidity in Older Adults in the United States by Race and Sex

Green MD, Mentz RJ, Greene SJ, Hammill BG, Essien UR, Xian Y, Michos ED, Thorpe RJ Jr, Dupre ME, Mac Grory B, Chiu CT, O'Brien[...]